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Abstract
Background: Intraventricular hemorrhage (IVH) is uncommon in term newborns. Asphyxia and hypothermia have
been mentioned separately as possible risk factors of IVH, since they might cause fluctuations of cerebral blood
flow. The aim of this study was to assess the incidence, the timing, and the risk factors of intraventricular
hemorrhage (IVH) in term asphyxiated newborns treated with hypothermia.
Methods: We conducted a prospective cohort study of all term asphyxiated newborns treated with hypothermia
from August 2008 to June 2013. The presence or not of IVH was assessed using brain magnetic resonance imaging
(MRI) performed after the hypothermia treatment was completed or using head ultrasound during the hypothermia
treatment. For these newborns, to determine the timing of IVH, we retrospectively reviewed if they had other brain
imaging studies performed during their neonatal hospitalization stay. In addition, we compared their general
characteristics with those not developing IVH.
Results: One hundred and sixty asphyxiated newborns met the criteria for hypothermia. Fifteen of these newborns
developed IVH, leading to an estimate of 9 % (95 % CI: 5.3-15.0 %) of IVH in this population of newborns. Fifty-three
percent had hemorrhage limited to the choroid plexus or IVH without ventricular dilatation; 47 % had IVH with
ventricular dilatation or parenchymal hemorrhage. Sixty-seven percent had an initial normal brain imaging; the
diagnostic brain imaging that demonstrated the IVH was obtained either during cooling (in 30 %), within 24 h of
the rewarming (in 30 %), or 24 h after the rewarming (in 40 %). Recurrent seizures were the presenting symptom of
IVH during the rewarming in 20 % of the newborns. Coagulopathy was more frequent in the asphyxiated newborns
developing IVH (p < 0.001). The asphyxiated newborns developing IVH also presented more frequently with
persistent pulmonary hypertension, hypotension, thrombocytopenia and coagulopathy (p = 0.03).
Conclusions: The asphyxiated newborns treated with hypothermia appear to be at an increased risk of IVH,
especially those with significant hemodynamic instability. IVH seems to develop during late hypothermia and
rewarming. Efforts should be directed towards maintaining hemodynamic stability in these patients, even during
the rewarming.
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Background
Intraventricular hemorrhage is uncommon in term new-
borns [1–3]. Asphyxia and hypothermia have been men-
tioned separately as possible risk factors of IVH, since
they might cause fluctuations of cerebral blood flow [3–5].
Neonatal encephalopathy in term newborns remain a ser-
ious condition responsible for significant mortality (i.e.,
23 % of all neonatal deaths worldwide or an estimated
900,000 deaths each year) [6–8] and long-term morbidity,
including cerebral palsy and intellectual disability. At
present, therapeutic hypothermia is the only available
neuroprotective treatment for these newborns [9], with an
improved survival and neurological outcome at 6 years
[10]. The IVH that develops in the context of neonatal
encephalopathy may cause an additional barrier for the
optimal development of these newborns. Studies are
needed to understand whether asphyxiated newborns
treated with hypothermia are at a greater risk of develop-
ing IVH, when they are the most at risk for it (i.e., during
hypothermia, during rewarming, or after the completion
of treatment), and what are the risk factors for developing
IVH. To our knowledge, the total body hypothermia
(TOBY) study group is the only hypothermia trial study
that has reported intracranial hemorrhage as an adverse
outcome in the context of neonatal encephalopathy and
therapeutic hypothermia, with a reported incidence of
intracranial hemorrhages in the hypothermic newborns of
39 % versus 31 % in the normothermic newborns. How-
ever, intracranial hemorrhages included 85 % of subdural
hematomas, and the exact frequency of IVH was not
described [11].
We hypothesized that asphyxiated newborns may be at
an increased risk of developing intraventricular hemorrhage
when treated with therapeutic hypothermia. Thus, the ob-
jective of this study was to determine the incidence of intra-
ventricular hemorrhage in term asphyxiated newborns
treated with hypothermia and to identify the timing and
risk factors associated with IVH.
Methods
We conducted a prospective cohort study of term as-
phyxiated newborns admitted to our neonatal intensive
care unit from August 2008 to June 2013, who met the
following criteria for induced hypothermia [11–13]: (1)
gestational age ≥ 36 weeks and birth weight ≥ 1800 g; (2)
evidence of fetal distress, i.e., history of an acute peri-
natal event, cord pH ≤ 7.0 or base deficit ≤ − 16 mEq/L;
(3) evidence of neonatal distress, such as an Apgar
score ≤ 5 at 10 min, postnatal blood gas pH obtained
within the first hour of life ≤ 7.0 or base deficit ≤ −
16 mEq/L, or a continued need for ventilation initiated
at birth and continued for at least 10 min; (4) evidence
of moderate to severe neonatal encephalopathy by an ab-
normal neurological exam and/or amplitude-integrated
electroencephalogram. Eligible patients received whole-
body cooling to an esophageal temperature of 33.5 °C,
initiated within the first 6 h of life, continued for 72 h,
and then they were slowly rewarmed using standard
protocol (i.e., temperature increase of 0.5 °C per hour).
The prospectively collected database, including clinical
characteristics, imaging results and placenta results was
approved by the Research Ethics Board of McGill
University Health Centre, who waived the need for in-
formed consent as data were collected from the charts
without requiring any additional testing in the newborns.
As per the current standard protocol in our neonatal in-
tensive care unit to evaluate for brain injury in these new-
borns, only a brain magnetic resonance imaging (MRI)
was performed after the hypothermia treatment was com-
pleted, except for the very sick newborns who may die
from the complications of neonatal encephalopathy for
whom a head ultrasound was requested at the bedside
during hypothermia treatment. The MRI scans were per-
formed using a 3 T clinical system (Achieva X, Philips
Healthcare, Best, The Netherlands). Each MRI study
included a 3D T1-weighted gradient-echo (TR/TE, 24/
4.6 ms; matrix size, 180 × 180; FOV, 180 mm; flip angle,
30 degree; 104 sagittal slices, with a section thickness of
1.0 mm and multiplanar reformations in axial and coronal
planes), a turbo spin-echo (TSE) high resolution T2-
weighted (TR/TE, 5000/90 ms; TSE factor, 15; matrix size,
300x300; FOV, 150 mm; flip angle, 90 degree; 27 axial sec-
tions, with a section thickness of 3.0 mm), a single shot
echo-planar imaging (EPI) diffusion-weighted imaging se-
quence (DWI) (TR/TE, 2424.4/69 ms; matrix size, 200 ×
117; FOV, 240 mm; b values 600 and 1200 s/mm2; flip
angle, 90 degree; 21 axial sections, with a section thickness
of 4.0 mm) and a gradient echo (GRE) T2*-weighted se-
quence (TR, shortest; TE, 16 ms; matrix size, 384 × 384;
flip angle, 18 degree; 21 axial sections, with a section
thickness of 4 mm). In addition, since 2010, when possible
(i.e., when the parents consented for their newborns to have
additional MRIs if the newborns were hemodynamically
stable and when a team of a nurse and a respiratory therap-
ist was available to go to the MRI), newborns were enrolled
in an MRI research study, and MRI scans were performed
on day 1 of life, day 2–3 of life, around day 10 of life and/or
around 1 month of life. These time-points were chosen to
ensure that no antenatal brain injury was present (day 1 of
life), to assess early patterns of injury (day 2–3 of life), and
to define the extent of definitive brain injuries (around day
10 of life and around 1 month of life). Patients receiving
hypothermia had their therapy maintained during the MRI
scan without any adverse events [14]. Any ventilation,
pressor support, or sedation was maintained during the
MRI scanning process; additional sedation was avoided. A
similar imaging protocol was used with these newborns at
the different time-points. The head ultrasound scans were
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performed at the bedside in the neonatal intensive care unit
according to standard protocols using a Toshiba Applio 2D
multifrequency 4.2-9.0 MHz pediatric head probe. All these
MRI scans and head ultrasounds were used to determine
the incidence of IVH among this population of newborns.
Neuroradiologists, who were blinded to the clinical condi-
tion of the newborns, interpreted the brain imaging stud-
ies of the asphyxiated newborns treated with hypothermia.
They reported the severity of intraventricular hemorrhage,
the presence and extent of brain injury as per the previ-
ously described magnetic resonance imaging scoring
system [15], and other intracranial bleeding. Intraventricu-
lar hemorrhage was categorized as either a hemorrhage
limited to the choroid plexus in the lateral ventricle, an
IVH without ventricular dilatation, an IVH with ventricu-
lar dilatation, or a parenchymal hemorrhage. For the new-
borns with IVH, we then retrospectively reviewed if they
had other brain imaging studies performed during their
neonatal hospitalization stay, since the attending physician
caring for the newborn may have decided to order add-
itional imaging.
The general characteristics of the newborns included in
our cohort were collected, including gestational age, birth
weight, sex, mode of delivery, Apgar score at 10 min, ar-
terial cord pH, initial blood gas pH, and highest serum
lactate level. The presence of possible symptoms of IVH
was recorded as well, including apneas, desaturations,
bradycardia, seizures, and lethargy.
The described risk factors for intraventricular
hemorrhage also were collected. The definition for
these risk factors was adapted from the Cochrane data-
base review of these patients [16] so we could compare
our numbers with those in the literature. Mechanical
ventilation was defined as the need for conventional
ventilation or an oscillator for ventilation. Persistent
pulmonary hypertension (PPHN) was diagnosed clinic-
ally when there was a persistent significant difference
of ≥ 10 in pre-ductal and post-ductal oxygen saturation
levels [16]; most often, an echocardiogram was also
performed to confirm the suprasystemic pulmonary
hypertension. Hypotension was defined as a mean arter-
ial pressure < 40 mmHg [15]. Thrombocytopenia was
defined as a platelet count < 50 x 109/L [16]. Coagulop-
athy was defined as a prolonged coagulation time or
hemorrhage [16]. Hypoglycaemia was defined as glu-
cose < 2.6 mmol/L on at least one occasion [16]. The
combination of persistent pulmonary hypertension,
hypotension, thrombocytopenia, and coagulopathy was
considered in this manuscript as hemodynamic instability.
Statistical analysis was performed to assess the differ-
ences between the newborns developing or not develop-
ing IVH. Differences were also evaluated between the
newborns with a hemorrhage limited to the choroid
plexus vessels in the lateral ventricle or an IVH without
ventricular dilatation and the newborns with an IVH
with ventricular dilatation or parenchymal hemorrhage.
Fisher’s exact tests were used for categorical data and
Mann–Whitney U tests for continuous data. A p value
< 0.05 was determined as significant.
Results
One hundred and sixty term asphyxiated newborns met the
criteria for therapeutic hypothermia. Fifteen of these new-
borns developed documented intraventricular hemorrhage,
leading to an estimate of 9 % (95 % CI: 5.3-15.0 %) of intra-
ventricular and/or intraparenchymal hemorrhage in this
population of newborns. Among them, 53 % (8/15) devel-
oped a hemorrhage limited to the choroid plexus in the
lateral ventricle or an IVH without ventricular dilatation;
47 % (7/15) had an IVH with ventricular dilatation or a par-
enchymal hemorrhage (Fig. 1). Three of these patients
(20 % [3/15]) died from the complications of neonatal
encephalopathy: two died before the hypothermia treat-
ment was completed, and one died at one week of life.
Among the fifteen asphyxiated newborns in our cohort
who developed intraventricular hemorrhage, 67 % (10/
15) had an initial brain imaging study that did not show
any intraventricular hemorrhage. In these patients, the
diagnostic brain imaging that permitted the demonstra-
tion of the intraventricular hemorrhage was obtained
either during cooling in 30 % (3/10), within 24 h of the
rewarming in 30 % (3/10), or 24 h after rewarming in
40 % (4/10) (Table 1).
Recurrent seizures appeared to be the presenting
symptoms of IVH in one of the asphyxiated newborns.
Two other newborns - who had episodes of seizures in
the first hours of life that initially were well controlled
with a single anti-epileptic medication - developed
refractory seizures coinciding with the time of the diag-
nosis of their IVH (Table 1). The recurrent seizures in
all three patients presented during the rewarming. No
other presenting symptoms such as apnea, desaturation,
bradycardia, desaturation, or lethargy were recorded. A
determination of the timing of the IVH was not possible
in the remaining newborns, since they did not have an
initial normal brain imaging performed before their
diagnostic imaging, and/or they did not develop any
symptoms.
The clinical characteristics of all the patients are
shown in Table 2. The gestational age, birth weight, sex,
Apgar score at 10 min, arterial cord pH, initial blood gas
pH, and highest serum lactate level were similar between
the asphyxiated newborns who developed and did not
develop IVH. Also, these characteristics were not differ-
ent according to the severity of the observed IVH. Males
who developed IVH presented more often with IVH
with ventricular dilatation or parenchymal hemorrhage
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rather than IVH limited to the choroid plexus vessels or
IVH without ventricular dilatation (p = 0.007).
The known risk factors of IVH were collected and are
shown in Table 3. Sixty-seven percent (10/15) of the as-
phyxiated newborns developing IVH needed mechanical
ventilation, with 46 % (6/13) still needing it during the
rewarming period. Forty percent (6/15) presented with
persistent pulmonary hypertension, with 38 % (5/13) re-
quiring inhaled nitric oxide through the rewarming
phase as well. Sixty-seven percent (10/15) presented
hypotension; and 54 % (7/13) still required inotropic sup-
port during the rewarming period. Thrombocytopenia
was present in 47 % (7/15) of the newborns, and coagu-
lopathy was present in 73 % (11/15) of them; and 46 %
(6/13) still presented significant thrombocytopenia and
coagulopathy throughout the rewarming. Hypoglycemia
was present in 20 % (3/15). Thirty-three percent (5/15) of
the newborns had a history of an instrumental assisted de-
livery. All asphyxiated newborns developing IVH with
ventricular dilatation or parenchymal hemorrhage who
presented with significant hypotension, persistent pul-
monary hypertension and coagulopathy during the
hypothermia treatment still had these risk factors present
during the rewarming period.
When comparing asphyxiated newborns developing IVH
to the asphyxiated newborns not developing IVH enrolled
in the cohort, coagulopathy was more frequent in these
IVH patients (p = 0.004). When compared separately,
mechanical ventilation, persistent pulmonary hypertension,
hypotension, thrombocytopenia, hypoglycemia, and trau-
matic delivery were not statistically different between the
two groups. However, when combining the risk factors
together, asphyxiated newborns developing IVH presented
significantly more often with a combination of persistent
pulmonary hypertension, hypotension, thrombocytopenia,
and coagulopathy (p = 0.04).
Brain MRIs after hypothermia or autopsy results
were obtained in 87 % (13/15) of the asphyxiated
newborns developing IVH. Brain injury was present
in 46 % (6/13) of them, with a watershed injury pat-
tern in 67 % (4/6) and a total cortical injury pattern
in 33 % (2/6). Sixty-one percent (8/13) had subdural
hematoma, and 8 % (1/13) had epidural hematomas.
None presented evidence of sinus venous thrombosis.
Discussion
The incidence of IVH was 9 % (95 % CI: 5.3-15.0 %) in
our cohort of asphyxiated newborns treated with
hypothermia, which is significantly higher than the re-
ported incidence of 3 % in term asymptomatic newborns
[1, 3]. Hypothermia and rewarming cause fluctuations of
cerebral blood flow [3–5, 17, 18], as well as depressed
Fig. 1 Brain magnetic resonance imaging in asphyxiated newborns treated with hypothermia who developed intraventricular hemorrhage, axial
T2-weighted imaging (superior row) and coronal T2-weighted imaging (inferior row). a Brain magnetic resonance imaging in an asphyxiated
newborn developing hemorrhage limited to the choroid plexus in the lateral ventricle (thick arrows). b Brain magnetic resonance imaging in an
asphyxiated newborn developing an IVH without ventricular dilatation, showing the intraventricular hemorrhage in the lateral ventricles and the
third ventricle (thick arrows) without dilatation of the ventricles. c Brain magnetic resonance imaging in an asphyxiated newborn developing IVH
with ventricular dilatation, showing the intraventricular hemorrhage with dilatation of the lateral ventricles and the third ventricle (thick arrows).
d Brain magnetic resonance imaging in an asphyxiated newborn developing IVH and parenchymal hemorrhage, showing a large right
intraventricular and parieto-occipital parenchymal hemorrhage (thick arrows) with some extension into the left ventricle. Possible infarcted
zones in the bilateral watershed areas were noted (thin arrow)
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cardiac function, hypotension, and some disturbances of
the coagulation profile [18]. Asphyxia in itself can have
similar effects. Another key factor is that asphyxia very
often leads to impaired cerebral autoregulation [17]. All
these factors may place the asphyxiated newborns treated
with hypothermia at an increased risk of developing IVH.
The timing of IVH in term infants has been poorly
studied. It has been reported within the first days of life
in those with perinatal risk factors, but up to 3–4 weeks
postnatally in those with no clear associated risk factor
[1–3]. Our results for asphyxiated newborns treated with
hypothermia suggest that IVH manifests most often
Table 1 Timing of imaging and seizures in term asphyxiated newborns treated with hypothermia developing intraventricular
hemorrhage (IVH)
Patient # Before or during
cooling Day 1 of life
During cooling
Days 2–4 of life
During rewarming
Day 4 of life
After cooling and
rewarming












developing IVH (n = 15)
Severity of IVH
IVH limited to the
choroid plexus vessels
in the lateral ventricles
or without ventricular
dilatation (n = 8)
1 HUS day 4 no
IVH
MRI day 7 IVH None subdural
hematomas




3 HUS day 3 no
IVH
MRI day 10 IVH None subdural
hematomas
4 HUS day 1 no IVH MRI day 4 IVH N/A CGM
+WM
None




6 MRI day 5 IVH N/A None None
7 MRI day 1 no IVH MRI day 2 IVH MRI day 10 IVH None subdural
hematomas




hemorrhage (n = 7)
9b seizure HUS day 4 IVH N/A N/A N/A
10 MRI day 3 no
IVH






11 MRI day 1 IVH MRI day 2 IVH MRI day 10 IVH None none
12 HUS day 1 no IVH CT day 5 IVH MRI day 10 IVH CGM
+WM
None
13 MRI day 3 IVH MRI day 10 IVH None subdural
hematomas
14a HUS day 1 no IVH HUS day 2 IVH N/A N/A N/A
15 HUS day 2 no
IVH




aEach MRI or autopsy was categorized as brain injury predominantly in the basal ganglia (BG), predominantly in the watershed areas (CGM +WM), or in the
cortical grey matter, white matter and basal ganglia (CGM +WM+ BG)
bThese patients died from the complications of neonatal encephalopathy. Patient #5 did not have a brain MRI to define the extent of brain injury, but had an
autopsy. Patients #9 and #14 did not have a brain MRI or an autopsy to define the extent of brain injury
Abbreviations: CT computed tomography, HUS head ultrasound, MRI magnetic resonance imaging, CGM cortical grey matter, WM white matter, BG basal ganglia
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during the later part of hypothermia (30 % diagnosed
during the latest segment of hypothermia) or during the
rewarming itself (70 % diagnosed after rewarming). This
period probably corresponds to the period of the largest
fluctuations of cerebral blood flow in these patients
[17, 18]. Hyperperfusion has been noted on days 2–3 of
life (i.e., during cooling) in the injured brain areas of these
newborns [17, 18]. Rewarming is supposed to restore the
cerebral blood flow within the normal range, after having
been decreased during hypothermia treatment. Peripheral
vasodilatation typically occurs during rewarming, which
increases the intravascular blood volume and often leads
to hypotension [19]. Rewarming also is thought to cause
a mismatch between oxygen delivery and consumption
[20, 21]. All these factors could explain why the greatest
risk of developing IVH in asphyxiated newborns treated
with hypothermia occurs during the latest part of
hypothermia or during the rewarming phase. To exactly
define the timing of IVH in this population, a systematic
study with brain imaging (head ultrasound or brain
magnetic resonance imaging) on admission and then
daily until after the rewarming should be performed. It
may help to determine if a brain imaging on admission
or during hypothermia may be a wise addition to the
standard imaging protocol for these newborns.
The pathogenesis of IVH in term newborns seems largely
related to the disturbances of cerebral blood flow [17, 18].
Respiratory distress and mechanical ventilation with fluctu-
ations of carbon dioxide levels can also increase the risk of
IVH in term newborns by causing perturbations of the
cerebral blood flow. Other factors that might cause abnor-
malities of cerebral blood flow include variations of arterial
blood pressure [22, 23]. In addition, thrombocytopenia is
another well-known risk factor [22, 24]. The role of coagu-
lopathy in the pathogenesis of IVH also has been
highlighted. In our cohort of asphyxiated newborns treated
with hypothermia, perinatal characteristics between both
groups (IVH versus no IVH) were the same, suggesting that
both groups had a similar degree of initial asphyxia. How-
ever, when comparing each known risk factor of IVH
between the two groups, coagulopathy played a significant
role, and thrombocytopenia tended also to be more fre-
quent in the asphyxiated newborns developing IVH. When
comparing the combined risk factors, the association of
four risk factors (i.e., mechanical ventilation, hypotension,
thrombocytopenia, and coagulopathy) was again signifi-
cantly more frequent in the asphyxiated newborns develop-
ing IVH, confirming that the most hemodynamically
unstable asphyxiated newborns (not unexpectedly) are
those at the greatest risk for developing IVH. This
increased risk was especially true for those newborns devel-
oping IVH with ventricular dilatation or parenchymal
hemorrhage.
Interestingly, the overall incidence of persistent pul-
monary hypertension and hypotension in our population
of newborns was higher compared to the available sys-
temic database review of asphyxiated newborns [16].
The incidence of persistent pulmonary hypertension was
15 % in the Cochrane database review [16] compared to
32 % in the newborns in our study not developing IVH
and 40 % of those who developed IVH in our study. The
incidence of hypotension was 51 % in the Cochrane
database review [16] versus 56 and 67 % in our popula-
tion of newborns. Our incidence of thrombocytopenia,
coagulopathy, and hypoglycemia was comparable with
that described in the Cochrane database systemic review
Table 2 Clinical characteristics of the study patients












p value IVH limited to the choroid
plexus vessels in the lateral
ventricles or IVH without
ventricular dilatation
(n= 8)






39.2 ± 1.5 39.1 ± 1.7 NS 39.5 ± 1.9 38.6 ± 1.3 NS
Birth weight (g), mean ± SD 3420 ± 652 3274 ± 659 NS 3422 ± 673 3091 ± 590 NS
Gender, n (%) NS 0,007
Male, n (%) 78 (54) 9 (60) 2 (25) 7 (100)
Female, n (%) 67 (46) 6 (40) 6 (75) 0 (0)
Apgar score < 5 at 10 min,
n (%)
74 (51) 8 (53) NS 7 (88) 5(71) NS
Arterial cord pH, mean ± SD 6,99 ± 0.20 7.03 ± 0.16 NS 7.00 ± 0.16 7.06 ± 0.16 NS
Initial postnatal blood gas pH,
mean ± SD
7.03 ± 0.19 7.07 ± 0.16 NS 7.09 ± 0.12 7.06 ± 0.19 NS
Highest lactate level (mmol/L),
mean ± SD
9.12 ± 5.67 10.02 ± 5.53 NS 9.36 ± 4.70 10.77 ± 6.66 NS
Abbreviations: IVH intraventricular hemorrhage, NS non-significant
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[16]. The incidence of thrombocytopenia was present in
31 % in the Cochrane database review [16] versus 23
and 47 % in our study. Coagulopathy was present in
31 % in the Cochrane database review [16] versus 32
and 73 % in our study. Hypoglycemia was present in
16 % in the Cochrane database review [16] versus 11
and 20 % in our study. In our population of patients,
these different risk factors seemed to slowly improve
over time, with a decreased incidence during the
rewarming mainly for the group with the IVH limited to
the choroid plexus or with IVH without associated doc-
umented ventricular dilatation.
Thirty-eight percent of the asphyxiated newborns de-
veloping IVH had signs of brain injury, 60 % presented
with a watershed injury pattern, and 40 % with a total
cortical injury pattern that included both white and
cortical gray matter injuries [15]. These parenchymal in-
juries possibly increase the fragility of brain tissue
around the ventricle, which may lead to the hemorrhagic
transformation of the tissue in the most susceptible pa-
tients. Interestingly, none of the asphyxiated newborns
developing IVH presented with a basal ganglia injury
pattern. Also, none of these patients presented with
obvious sinus venous thrombosis, one of the most com-
monly reported risk factors for IVH in term newborns in
the literature [25].
The main limitation of this study is that it is a cohort
study; a randomized control trial would have been more
ideal to address whether the incidence of IVH is increased
when the newborns are treated with hypothermia. How-
ever, as cooling is now the standard of care, it is no longer
possible to randomize infants to cooling or not to assess











p value IVH limited to the choroid
plexus vessels in the lateral












145 (100) 15 (100) - 8 (100) 7 (100) -
Brain hypoxic-
ischemic injury, n (%)




145 (100) 15 (100) - 8 (100) 7 (100) −
Hemodynamic instability
Mechanical ventilation, n (%) 98 (68) 10 (67) NS 4 (50) 5(71) NS
Lowest pCO2 level 29.2 ± 8.78 28.7 ± 4.2 NS 30.1 ± 3.4 26.8 ± 4.8 NS
Highest pCO2 level 55.4 ± 15.6 57.1 ± 12.7 NS 55.7 ± 13.4 59.0 ± 12.6 NS
Highest pCO2variations 27.0 ± 15.6 28.4 ± 15.1 NS 25.6 ± 15.6 32.2 ± 14.8 NS
Duration of mechanical
ventilation, days
3.3 ± 5.0 3.5 ± 4.1 NS 1.4 ± 1.9 5.8 ± 4.8 NS
Persistent pulmonary
hypertension, n (%)
46 (32) 6 (40) NS 2(25) 4(57) NS
Hypotension, n (%) 81 (56) 10 (67) NS 5 (63) 5(71) NS
Hemostasis disturbances
Thrombocytopenia, n (%) 34 (23) 7(47) NS 2(25) 5(71) NS
Coagulopathy, n (%) 46 (32) 11 (73) 0.004 7(88) 4(57) NS
Metabolic disturbances
Hypoglycemia, n (%) 16 (11) 3 (20) NS 1 (13) 2 (29) NS
Other
Venous sinus thrombosis, n (%) 3(2) 0(0) NS 0(0) 0(0) -
Traumatic birth/instrumental
delivery, n (%)
34 (23) 5 (33) NS 2(25) 3(43) NS
aTwo patients did not have a brain MRI or an autopsy to define the extent of brain surgery.
Abbreviations: IVH intraventricular hemorrhage, NS non-significant
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the complications of cooling for neonatal encephalopathy
such as IVH. As such, this cohort study is the most feas-
ible means of addressing the question. Also only 15 new-
borns developed documented intraventricular and/or
intraparenchymal hemorrhage - a relatively small number
that did not allow us to conduct a multivariate regression
analysis due to the limited number of IVH cases. Only
studies that could combine several databases of such pa-
tients in a systematic way would provide a large enough
sample to conclude whether the trends observed in the
present study could be confirmed. Another limitation of
our study is that it did not have a uniform protocol for re-
peated imaging (magnetic resonance imaging and/or head
ultrasounds) during hypothermia - except for the new-
borns enrolled in the MRI research study - that was used
prospectively to determine the timing of IVH. It may be
worthwhile to develop such a protocol to determine
whether the incidence of IVH was underestimated in our
study. This protocol should include a gradient echo (GRE)
T2*-weighted sequence or a susceptibility-weighted im-
aging (SWI) sequence to ensure the adequate visualization
of the IVH. However, despite these limitations, the results
presented here remain of interest, since the major random-
ized controlled studies about hypothermia in asphyxiated
newborns [10–13] did not address this issue, and, if in truth
a threefold increase in IVH risk exists for infants undergo-
ing hypothermia, this risk could impact management, espe-
cially regarding the maintenance of hemodynamic stability
and rewarming.
Conclusions
Asphyxiated newborns treated with hypothermia may be
at an increased risk of intraventricular hemorrhage, es-
pecially those with significant hemodynamic instability.
Intraventricular hemorrhage seems to develop most
often during the latest part of hypothermia treatment or
during the rewarming. Thus, efforts should be directed
towards maintaining hemodynamic stability in these pa-
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